Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Beta Bionics, Inc. - Common Stock (NQ:BBNX)

19.09 -0.24 (-1.24%)
Streaming Delayed Price Updated: 11:44 AM EDT, Sep 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 134,264
Open 19.14
Bid (Size) 19.06 (200)
Ask (Size) 19.12 (200)
Prev. Close 19.33
Today's Range 18.90 - 19.54
52wk Range 8.800 - 32.71
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm Encourages Beta Bionics, Inc. (BBNX) Shareholders To Inquire About Securities Fraud Class Action
From Glancy Prongay Wolke & Rotter LLP
Via Business Wire
News headline image
Law Offices of Howard G. Smith Encourages Beta Bionics, Inc. (BBNX) Shareholders To Inquire About Securities Fraud Class Action
From Law Offices of Howard G. Smith
Via Business Wire

Performance

YTD
-34.7%
-34.7%
1 Month
+16.4%
+16.4%
3 Month
+32.7%
+32.7%
6 Month
+74.0%
+74.0%
1 Year
-17.5%
-17.5%

More News

Read More
News headline image
BBNX INVESTOR ALERT: Securities Class Action Filed Against Beta Bionics, Inc. – Investors Encouraged to Contact Kirby McInerney LLP
From Kirby McInerney LLP
Via Business Wire
Beta Bionics (NASDAQ:BBNX) Q2: EPS Beat and Margin Progress Lift Shares 3% After Hours ↗
Via Chartmill
News headline image
BBNX DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Beta Bionics (NASDAQ: BBNX) Investors of Securities Class Action Lawsuit Deadline on November 3, 2026
From Faruqi & Faruqi, LLP
Via Business Wire
News headline image
BETA BIONICS, INC. (BBNX) INVESTOR ALERT Investors With Large Losses in Beta Bionics, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights
From Bernstein Liebhard LLP
Via GlobeNewswire
News headline image
Beta Bionics, Inc. Notice of November 3, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Rosen Law Firm Urges Beta Bionics, Inc. (NASDAQ: BBNX) Stockholders to Contact the Firm for Information About Their Rights
From The Rosen Law Firm, P.A.
Via Business Wire
News headline image
BBNX Investor Alert: Schall, Brown & Schwartz LLP Files Class Action Lawsuit Against Beta Bionics, Inc. and Announces Opportunity for Investors to Lead Class Action Lawsuit
From Schall, Brown & Schwartz LLP
Via GlobeNewswire
News headline image
Beta Bionics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – BBNX
From DJS Law Group
Via Business Wire
News headline image
Investor Alert: Robbins LLP Informs Investors of the Beta Bionics Inc. Class Action Lawsuit
From Robbins LLP
Via Business Wire
News headline image
BBNX Investor Alert: Schall, Brown & Schwartz LLP Files Class Action Lawsuit Against Beta Bionics, Inc. and Announces Opportunity for Investors to Lead Class Action Lawsuit
From Schall, Brown & Schwartz LLP
Via Business Wire
News headline image
Beta Bionics (BBNX) Q2 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Beta Bionics Q2 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
News headline image
Beta Bionics Announces Second Quarter 2026 Financial Results and Updates Full Year 2026 Guidance
From Beta Bionics, Inc.
Via GlobeNewswire
News headline image
Beta Bionics to Announce Second Quarter 2026 Financial Results on July 29, 2026
From Beta Bionics, Inc.
Via GlobeNewswire
News headline image
Johnson Fistel Continues Investigation of Beta Bionics, Inc. (BBNX)
From Johnson Fistel, PLLP
Via Business Wire
News headline image
Beta Bionics Investors Suffer Significant Losses After Company Reports Slower New Patient Start Growth; Contact Johnson Fistel
From Johnson Fistel, PLLP
Via Business Wire
News headline image
Beta Bionics First in Automated Insulin Delivery to Publish Near Real-Time Real-World Data on a Public Website
From Beta Bionics, Inc.
Via GlobeNewswire
News headline image
Robbins LLP is Investigating Allegations that the Officers and Directors of Beta Bionics, Inc. (BBNX) Violated Securities Laws and Breached Fiduciary Duties to Shareholders
From Robbins LLP
Via Business Wire
News headline image
Beta Bionics Updates Commercialization Timeline Expectations for Mint™, its Patch Pump in Development
From Beta Bionics, Inc.
Via GlobeNewswire
News headline image
Bicara Stock Is Up 50%, and One Biotech Investor Has Made It a 29% Portfolio Bet ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Alumis Stock Is Up Over 300%. One Major Healthcare Investor Is Cutting Back ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Kestra Medical Grew Revenue 63%. One Fund Still Trimmed 351,000 Shares ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Beta Bionics Touts Pharmacy Push, iLet Momentum and 2027 Mint Patch Pump Plans ↗
Via MarketBeat

Frequently Asked Questions

Is Beta Bionics, Inc. - Common Stock publicly traded?
Yes, Beta Bionics, Inc. - Common Stock is publicly traded.
What exchange does Beta Bionics, Inc. - Common Stock trade on?
Beta Bionics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Beta Bionics, Inc. - Common Stock?
The ticker symbol for Beta Bionics, Inc. - Common Stock is BBNX on the Nasdaq Stock Market
What is the current price of Beta Bionics, Inc. - Common Stock?
The current price of Beta Bionics, Inc. - Common Stock is 19.09
When was Beta Bionics, Inc. - Common Stock last traded?
The last trade of Beta Bionics, Inc. - Common Stock was at 09/09/26 11:44 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.